NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Jana Partners Says Alkami Is Undervalued and Should Consider a Sale

Activist investor Jana Partners believes Alkami Technology is undervalued and should consider a sale to a larger tech firm or private equity due to its strong growth and customer retention.

Jana Partners Says Alkami Is Undervalued and Should Consider a Sale
Credit: Alkami Technology
Already have an account? Sign in.
12/09/2025 · 4:06 PM
ALKT
/ Don’t stop at just one post.

Related↓

Alkami Technology Explores Possible Sale After Investor Pressure
01/28/2026 · 3:48 PM

Alkami Technology Explores Possible Sale After Investor Pressure

Alkami Technology is reviewing strategic options, including a possible sale, after pressure from an activist investor.

/ Subscriber only
/ Read more

Feed↓

Zymeworks to Acquire Theravance Biopharma for $17 Per Share in Cash Plus CVR
Featured/ 06/29/2026 · 6:23 AM

Zymeworks to Acquire Theravance Biopharma for $17 Per Share in Cash Plus CVR

The deal adds YUPELRI to Zymeworks’ portfolio.

/ Subscriber only
Wall Street Goes Bullish on Quantinuum: Jefferies and JPMorgan Initiate Coverage with Strong Buy Ratings
Featured/ 06/29/2026 · 6:02 AM

Wall Street Goes Bullish on Quantinuum: Jefferies and JPMorgan Initiate Coverage with Strong Buy Ratings

Jefferies starts Quantinuum at Buy with $90 target (19% upside), JPMorgan adds Overweight at $97. Full-stack quantum leader sees strong Wall Street support.

/ Subscriber only
TeraWulf’s Aggressive HPC and AI Push Wins Citi Backing
06/29/2026 · 5:41 AM

TeraWulf’s Aggressive HPC and AI Push Wins Citi Backing

Wall Street consensus is Strong Buy at $36.34, implying 40% upside as the company pivots aggressively into AI and HPC infrastructure.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe